Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT05223673 · TERMINATED
Trial details
- NCT number
- NCT05223673
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2023-06-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.